Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cybin Inc N.CYBN

Alternate Symbol(s):  CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary... see more

Bullboard (NEO:CYBN)

View:
Comment by realitycheck00on Sep 04, 2021 2:59pm

RE:RE:RE:MILESTONES

Read the acquisition press release as you are beyond confused.  The acquisition based part of the price as broken down into milestone payments.  i.e Adelia would recieve part of the ...more  
Comment by Gordinnoon Sep 03, 2021 9:45am

RE:RE:MILESTONES

Yes it certainly looks like the market agrees with you when they announce this every month..Not confused ,know a scam when i see it just as the market does..GL
Comment by realitycheck00on Sep 02, 2021 2:45pm

RE:MILESTONES

You do realize those milestones are for the Adelia acquisition and the team that came from Adelia.  An acquisition that Cybin got for a great deal which now is the reason all the IP exists.  ...more  
Post by Gordinnoon Sep 01, 2021 3:49pm

MILESTONES

Just another dilution tactic where management line there own pockets. Unbelievable
Comment by Alim33on Sep 01, 2021 9:36am

RE:Halted!

Not halted anymore.  Strange.
Post by Betteryear2on Aug 19, 2021 4:33pm

Files Two Additional International Patent Applications

Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed two additional ...more  
Post by Gordinnoon Aug 18, 2021 11:57am

Reverse Soon

Will start reversing soon as ot filled the gap at $ 2.30
Post by Betteryear2on Aug 17, 2021 7:51am

Files 14th Patent Application

Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed a new non ...more  
Post by thorgb1on Aug 13, 2021 9:12am

News: Adelia milestones….

News here: https://www.businesswire.com/news/home/20210812005267/en/
Post by Gordinnoon Aug 09, 2021 11:15am

Terrible Management

Line there pockets and fked over share holders.Would have been at 4.50 if they were not  so inept and greedy
Post by thorgb1on Aug 09, 2021 9:56am

News: presenting at conference….

News here: https://www.businesswire.com/news/home/20210809005079/en/
Comment by Gordinnoon Aug 05, 2021 10:27am

RE:News: trading tomorrow on the NYSE….

Does not matter .PP  killed this especially at 3.40  That was a kick in the nutz for those investors who were paying close to 3.95
Post by thorgb1on Aug 04, 2021 7:44am

News: trading tomorrow on the NYSE….

News here: https://www.businesswire.com/news/home/20210804005381/en/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities